Axis Research Scorecard Report - Sep 22
Axis Top Picks basket reported a resilient performance with an astounding return of 143% since its inception, notably beating an 84% return...
284 Views
Abbott India Ltd - Key Therapies Report Robust Sales Improvement
AIL reported revenue growth of 7.1% YoY in Q1FY23 (vs. our expectations of 8% YoY), outpacing the IPM* growth of 2.0% (IPM: Indian Pharma Industry,...
297 Views
Pharma Q4FY22 Preview: Cost Pressure and Pricing Erosion Compress Margins
We expect companies under our Pharma coverage to report high singledigit growth (6.2% YoY), primarily driven by Injectable and Generic segment.
255 Views
Pick of the Week: Abbott India Ltd
Revenue growth of Abbott India Ltd (AIL) for FY21 has outpaced the Indian Pharma Market (IPM) growth by 100 bps majorily contributed by addition of...
193 Views
Abbott India: Key Therapies Report Robust Sales Improvement
AIL reported revenue growth of 15.9% in Q2FY22, outpacing the IPM (Indian Pharma Industry, Source: AIOCD) growth of 14.6%.
170 Views